ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Alpha-Lipoic Acid as a Therapeutic Agent in a Rat Model of Ibuprofen-Induced Liver Fibrosis

Gülhan Ünlü,Kübra Tuğçe Kalkan.



Abstract
Download PDF Post

Aim: Ibuprofen (IBU), a commonly used nonsteroidal anti-inflammatory drug, may cause hepatotoxicity and fibrosis with prolonged or high-dose use. Alpha-lipoic acid (ALA), a natural antioxidant, has shown protective effects against oxidative stress and liver injury. This study evaluated the potential therapeutic role of ALA in IBU-induced liver fibrosis.
Methods: Thirty male Wistar Albino rats were divided into five groups (n=6): Control, Sham (corn oil), IBU (200 mg/kg, 21 days), IBU+ALA (IBU for 21 days followed by ALA 100 mg/kg for 7 days), and ALA (100 mg/kg for 7 days). Liver tissue was analyzed histopathologically with hematoxylin-eosin and Masson’s trichrome staining, and immunohistochemically for TLR-4, TGF-β, and α-SMA expression. Statistical analyses were performed using ANOVA, Tukey’s test, Kruskal-Wallis, and Mann-Whitney U tests.
Results: IBU caused significant hydropic degeneration, sinusoidal dilatation, and perivascular collagen accumulation compared to controls (p

Key words: Ibuprofen; Alpha-lipoic acid; Fibrosis; Rat







Bibliomed Article Statistics

3
R
E
A
D
S


D
O
W
N
L
O
A
D
S
06
2026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.